 |
The Journal of Neuroscience, January 17, 2007, 27(3):496-506; doi:10.1523/JNEUROSCI.4644-06.2007
Previous Article | Next Article 
Cellular/Molecular
Tonic Enhancement of Endocannabinoid-Mediated Retrograde Suppression of Inhibition by Cholinergic Interneuron Activity in the Striatum
Madoka Narushima,1,2,3
Motokazu Uchigashima,4
Masahiro Fukaya,4
Minoru Matsui,5
Toshiya Manabe,3,5
Kouichi Hashimoto,1,3
Masahiko Watanabe,4 and
Masanobu Kano1,2
1Department of Cellular Neuroscience, Osaka University, Graduate School of Medicine, Yamada-oka, Suita 565-0871, Japan, 2Department of Cellular Neurophysiology, Graduate School of Medical Science, Kanazawa University, Takara-machi, Kanazawa 920-8640, Japan, 3Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Tokyo 102-8666, Japan, 4Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, Japan, and 5Division of Neuronal Network, Department of Basic Medical Sciences, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Correspondence should be addressed to Masanobu Kano, Department of Cellular Neuroscience, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan. Email: mkano{at}cns.med.osaka-u.ac.jp
Tonically active cholinergic interneurons in the striatum modulate activities of striatal outputs from medium spiny (MS) neurons and significantly influence overall functions of the basal ganglia. Cellular mechanisms of this modulation are not fully understood. Here we show that ambient acetylcholine (ACh) derived from tonically active cholinergic interneurons constitutively upregulates depolarization-induced release of endocannabinoids from MS neurons. The released endocannabinoids cause transient suppression of inhibitory synaptic inputs to MS neurons through acting retrogradely onto presynaptic CB1 cannabinoid receptors. The effects were mediated by postsynaptic M1 subtype of muscarinic ACh receptors, because the action of a muscarinic agonist to release endocannabinoids and the enhancement of depolarization-induced endocannabinoid release by ambient ACh were both deficient in M1 knock-out mice and were blocked by postsynaptic infusion of guanosine-5'-O-(2-thiodiphosphate). Suppression of spontaneous firings of cholinergic interneurons by inhibiting Ih current reduced the depolarization-induced release of endocannabinoids. Conversely, elevation of ambient ACh concentration by inhibiting choline esterase significantly enhanced the endocannabinoid release. Paired recording from a cholinergic interneuron and an MS neuron revealed that the activity of single cholinergic neuron could influence endocannabinoid-mediated signaling in neighboring MS neurons. These results clearly indicate that striatal endocannabinoid-mediated modulation is under the control of cholinergic interneuron activity. By immunofluorescent and immunoelectron microscopic examinations, we demonstrated that M1 receptor was densely distributed in perikarya and dendrites of dopamine D1 or D2 receptor-positive MS neurons. Thus, we have disclosed a novel mechanism by which the muscarinic system regulates striatal output and may contribute to motor control.
Key words: CB1 receptor; acetylcholine; muscarinic receptor; DSI; medium spiny neuron; basal ganglia
Received Oct. 26, 2006;
revised Nov. 28, 2006;
accepted Nov. 29, 2006.
Correspondence should be addressed to Masanobu Kano, Department of Cellular Neuroscience, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan. Email: mkano{at}cns.med.osaka-u.ac.jp
This article has been cited by other articles:

|
 |

|
 |
 
M. Brusberg, S. Arvidsson, D. Kang, H. Larsson, E. Lindstrom, and V. Martinez
CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents
J. Neurosci.,
February 4, 2009;
29(5):
1554 - 1564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe
Endocannabinoid-Mediated Control of Synaptic Transmission
Physiol Rev,
January 1, 2009;
89(1):
309 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Lau and C. W. Vaughan
Muscarinic Modulation of Synaptic Transmission via Endocannabinoid Signalling in the Rat Midbrain Periaqueductal Gray
Mol. Pharmacol.,
November 1, 2008;
74(5):
1392 - 1398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Sullivan, H. Chen, and H. Morikawa
Recurrent Inhibitory Network among Striatal Cholinergic Interneurons
J. Neurosci.,
August 27, 2008;
28(35):
8682 - 8690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimotodani, T. Ohno-Shosaku, M. Watanabe, and M. Kano
Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release
J. Physiol.,
October 15, 2007;
584(2):
373 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miura, S. Saino-Saito, M. Masuda, K. Kobayashi, and T. Aosaki
Compartment-Specific Modulation of GABAergic Synaptic Transmission by {micro}-Opioid Receptor in the Mouse Striatum with Green Fluorescent Protein-Expressing Dopamine Islands
J. Neurosci.,
September 5, 2007;
27(36):
9721 - 9728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Uchigashima, M. Narushima, M. Fukaya, I. Katona, M. Kano, and M. Watanabe
Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum
J. Neurosci.,
April 4, 2007;
27(14):
3663 - 3676.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|